- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Roche and Spark announce All antitrust approvals required to close the transaction received
Dec 17, 2019
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
May 19, 2020
Asia Pacific Pharmaceutical Drug Delivery Market is anticipated to grow during 2019-2027 with a CAGR value of 7.1%
Aug 04, 2020
Christopher Hite Joins Royalty Pharma
Feb 28, 2020
Athlete Endorsements Help Drive the CBD Industry to New Heights
Oct 25, 2019
FDA Approves Harmony Biosciences' Sleep Disorder Drug
Sep 04, 2019
What Is Human Serum Albumin and How It Drives Modern Medicine
Feb 25, 2026
Follow us on
